Blogs for 五月 2017

Actual Living Scientist – Martin Ramsden

星期二, 五月 30, 2017 - 10:10
Martin Ramsden, Commercial Development Manager

It recently came to our attention, from this article, that only one in three Americans can name an actual living scientist. As a large biotechnology company, filled with talented and dedicated scientists, we think that is ridiculous. We want to introduce you to some of our staff who are, in fact, Actual Living Scientists.

The next scientist in our series is Martin Ramsden, PhD. Martin has been with Bio-Techne for 8 years at the R&D Systems site (and Bio-Techne Headquarters) in Minneapolis, MN. Martin works in our Commerical Development Department, which develops...

New Scientific Poster Presented AAI 2017

星期四, 五月 25, 2017 - 10:01
M1 and M2a Macrophage Phenotypic Characterization Poster
 

Bio-Techne scientists presented a poster at AAI 2017 demonstrating the effects that cell culture conditions can have on the phenotypic characterization of human M1 and M2a macrophages. This poster compared the expression of fifty macrophage cell surface markers, leading to the identification of twenty markers that were affected by culturing in the presence of fetal bovine serum (FBS), human serum, or StemXVivo® Serum-Free Dendritic Cell Base Media. Each condition was performed with and without polarizing stimuli.

Download the poster to learn more about the...

Actual Living Scientist – Kristin Jacobsen

星期一, 五月 22, 2017 - 11:37
Kristin Jacobsen

It recently came to our attention, from this article, that only one in three Americans can name an actual living scientist. As a large biotechnology company, filled with talented and dedicated scientists, we think that is ridiculous. We want to introduce you to some of our staff who are, in fact, Actual Living Scientists.

The next scientist in our series is Kristin Jacobsen. Kristin just celebrated 6 years with Bio-Techne at the R&D Systems site (and Bio-Techne Headquarters) in Minneapolis, MN. Kristin not only works in Protein Development, she also recently completed her MBA at the University of...

Introducing Our Quarterly Protein Update!

星期一, 五月 22, 2017 - 11:21
Protein Structure Banner
 
Anthony Person, Ph.D.
Next Generation Targets for Immuno-Oncology!
On May 4th Bio-Techne hosted a webinar on Next Generation Targets for Immunotherapy. Bio-Techne scientist, Anthony Person, Ph.D., discussed novel immunoregulatory pathways that the R&D Systems protein group has uncovered as potential targets for cancer immunotherapy. Watch now!
...

Post AACR Blog #2: Cancer Immunotherapy

星期二, 五月 16, 2017 - 12:08
Bio-Techne Bubble

The ability to mobilize the immune system to fight cancer has revolutionized the way we treat this disease. It’s no surprise that Cancer Immunotherapy was a prominent topic at the 2017 American Association for Cancer Research (AACR) annual meeting. Despite the successes associated with immunotherapy there are still many questions to be answered. Investigators at AACR provided a nice framework for future research by posing both big picture and mechanistic questions. Why does immunotherapy work only for a small percentage of patients? What are the mechanisms of cancer resistance and how can we overcome them? What role does the tumor microenvironment play? What model system is most appropriate for preclinical studies? What about combination therapy? How do you evaluate the utility...

Actual Living Scientist – Kylie Bruner

星期一, 五月 15, 2017 - 09:35
Kylie Bruner

It recently came to our attention, from this article, that only one in three Americans can name an actual living scientist. As a large biotechnology company, filled with talented and dedicated scientists, we think that is ridiculous. We want to introduce you to some of our staff who are, in fact, Actual Living Scientists.

The next scientist in our series is Kylie Bruner. Kylie has been with Bio-Techne for just under 1 year at the R&D Systems site (and Bio-Techne Headquarters) in Minneapolis, MN. Kylie works in our Proteins Purification Department, which is the starting point for many of the high quality...

Neuroscience Research Review: Stanford Team Finds A1 Astrocytes are Induced by Activated Microglia

星期五, 五月 12, 2017 - 07:45
Activated Microglia Induce the Formation of A1 Astrocytes

Astrocytes are the most numerous glia cells in the central nervous system (CNS). They help to maintain the health and function of the CNS, by providing metabolic support to neurons, clearing neurotransmitters from synapses, supporting blood-brain barrier endothelial cells, regulating extracellular ion concentrations, forming and maturating synapses, and modulating synaptic plasticity. Astrocytes have also been implicated in neurodegenerative diseases. CNS injury and disease induce astrocytes to undergo reactive astrogliosis, which involves both biochemical and structural changes to astrocytes. Previous studies from the lab of Dr. Ben Barres at Stanford University School of Medicine characterized two different types...

Bio-Techne Go Everywhere Travel Grant – April Recipient Selected!

星期三, 五月 10, 2017 - 15:03
Bio-Techne travel grants

April 2017 Go Everywhere with Bio-Techne Travel Grant Awarded to PhD Candidate at The University of Bonn!

Bio-Techne launched its Go Everywhere Travel Grant Program which awards $1000 USD (or equivalent) to 1 researcher each month to attend the meeting of their choice. This grant program allows the researcher to attend more targeted meetings in their field and provides funding to support both small and large scientific associations that promote discovery and collaboration.

The recipient of the April 2017 grant is Janine Groß, a PhD Candidate at the University of Bonn!

...

Stem Cells in the News – May 2017

星期三, 五月 10, 2017 - 14:06
Stem Cells in the News

We have captured this month's most interesting, innovative, and maybe some of the strangest examples of stem cells in the news from around the world.

Sparking Faster MSC Differentiation into Schwann-Like Cells - Iowa State University
Researchers at Iowa State University have developed a nanotechnology that uses a 3-D Nanostructure and circuit boards that stimulates the differentiation of Mesenchymal Stem Cells (MSCs) into Schwann-like cells. Their technology could be the solution to an otherwise long and expensive process by which MSCs are pushed to a Schwann-like fate and could hold promise in accelerating studies looking to promote...

AACR Recap #1: New Biomarker Candidates!

星期一, 五月 8, 2017 - 13:30
Cancer biomarkers

Most investigators agree that early detection increases the likelihood of a positive response to a given therapeutic intervention in cancer. Biomarkers are a necessary prerequisite for early detection. A healthcare provider needs some clue that cancer is likely to develop. More importantly, they need to know that the selected therapeutic intervention will be effective. It is no surprise then, that much of the work presented at the 2017 American Association for Cancer Research (AACR) was focused on discovering and validating novel cancer biomarkers.

Mahoney and Atkins describe four types of cancer biomarkers: diagnostic,...

Actual Living Scientist – Dr. Louis Leong

星期一, 五月 8, 2017 - 08:33
Dr. Louis Leong of Bio-Techne

It recently came to our attention, from this article, that only one in three Americans can name an actual living scientist. As a large biotechnology company, filled with talented and dedicated scientists, we think that is ridiculous. We want to introduce you to some of our staff who are, in fact, Actual Living Scientists.

The first scientist in our series is Dr. Louis Leong. Dr. Leong has been with Bio-Techne at the R&D Systems site (and Bio-Techne Headquarters) in Minneapolis, MN for 5 years. Dr. Leong completed a Post Doc at UC-Irvine in 2000 before moving into industry at...